We are live on
!
Find out more
Royalty Pharma
RPRX
RPRX
236 hedge funds and large institutions have $10.3B invested in Royalty Pharma in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 57 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 32
60% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 57
11% more funds holding
Funds holding: 213 → 236 (+23)
0.01% more ownership
Funds ownership: 63.74% → 63.75% (+0.01%)
5% less capital invested
Capital invested by funds: $10.8B → $10.3B (-$488M)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
28% less call options, than puts
Call options by funds: $34.6M | Put options by funds: $48M
Holders
236
Holders Change
+23
Holders Change %
+10.8%
% of All Funds
4.11%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.16%
New
56
Increased
91
Reduced
57
Closed
32
Calls
$34.6M
Puts
$48M
Net Calls
-$13.4M
Net Calls Change
-$14.3M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$114M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$107M |
| 3 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$78.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$77.8M |
| 5 |
JP Morgan Chase
New York
|
+$64.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$164M |
| 2 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$152M |
| 3 |
BlackRock
New York
|
-$144M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$83.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$82.3M |
